Parsons Capital Management Inc Gilead Sciences, Inc. Transaction History

Parsons Capital Management Inc

$1.55 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $30,327 - $34,593	-399 Reduced 7.72%	4,768 $367,000
Q1 2023 Apr 17, 2023	BUY	$77.31 - $88.08 $77 - $88	1 Added 0.02%	5,167 $428,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $1,059 - $1,520	-17 Reduced 0.33%	5,166 $443,000
Q2 2022 Jul 29, 2022	SELL	$57.72 - $65.01 $5,310 - $5,980	-92 Reduced 1.74%	5,183 $320,000
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $4,344 - $5,443	75 Added 1.44%	5,275 $314,000
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $3,633 - $4,123	56 Added 1.09%	5,200 $378,000
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $10,018 - $10,808	-148 Reduced 2.8%	5,144 $359,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $9,520 - $10,402	-150 Reduced 2.76%	5,292 $364,000
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $20,760 - $23,687	-346 Reduced 5.98%	5,442 $352,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $129,898 - $148,013	-2,293 Reduced 28.38%	5,788 $337,000
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $13,351 - $16,787	215 Added 2.73%	8,081 $511,000
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $38,918 - $45,192	538 Added 7.34%	7,866 $605,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $41,335 - $52,945	-660 Reduced 8.26%	7,328 $548,000
Q4 2019 Feb 03, 2020	SELL	$61.62 - $67.78 $18,486 - $20,334	-300 Reduced 3.62%	7,988 $519,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $172,527 - $190,440	-2,760 Reduced 24.98%	8,288 $525,000
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $8,971 - $10,060	-145 Reduced 1.3%	11,048 $746,000
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $26,887 - $30,121	-430 Reduced 3.7%	11,193 $728,000
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $14,226 - $18,565	-235 Reduced 1.98%	11,623 $727,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $2,423 - $2,683	34 Added 0.29%	11,858 $916,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $583 - $681	9 Added 0.08%	11,824 $0
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $40,062 - $48,840	-550 Reduced 4.45%	11,815 $891,000
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $17,787 - $20,880	-250 Reduced 1.98%	12,365 $886,000
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $909,667 - $1.08 Million	12,615	12,615 $1.02 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Account